CVS Health Corporations in-depth stock price analysis indicates that the stock price has rallied 6.06% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -15.8% . Looking at the past 52 week period, the stock price is down -18.08% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of CVS Health Corporation has a negative value of -23.93 compared to overall market performance. Stocks of CVS Health Corporation (NYSE:CVS) rallied by 4.07% during the past week but lost 4.21% on a 4-week basis. The company has outperformed the S&P 500 by 3.23% in the past week but underperformed the index by 5.92% in the last 4 weeks.
CVS Health Corporation (NYSE:CVS) : On Friday heightened volatility was witnessed in CVS Health Corporation (NYSE:CVS) which led to swings in the share price. The stock opened for trading at $77.44 and hit $79.12 on the upside , eventually ending the session at $78.53, with a gain of 1.58% or 1.22 points. The heightened volatility saw the trading volume jump to 9,366,970 shares. The 52-week high of the share price is $106.67 and the company has a market cap of $80,548 million. The 52-week low of the share price is at $69.3 .
CVS Health Corp Last issued its quarterly earnings results on Feb 9, 2017. The company reported $1.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.04. Analyst had a consensus of $1.67. The company had revenue of $45971.00 million for the quarter, compared to analysts expectations of $46513.84 million. The companys revenue was up 11.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.53 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.CVS Health Corp was Downgraded by Atlantic Equities to Neutral on Feb 6, 2017. CVS Health Corp was Downgraded by Robert W. Baird on Feb 2, 2017 to Neutral, Lowers Price Target to $ 77 from a previous price target of $86 .CVS Health Corp was Downgraded by Jefferies to Hold on Dec 12, 2016.
Company has reported several Insider transactions to the SEC, on Feb 3, 2017, Larry J Merlo (President and CEO) sold 76,494 shares at 78.32 per share price.On May 6, 2016, Troyen A Brennan (EVP and Chief Medical Officer) sold 7,517 shares at 105.00 per share price.On Apr 5, 2016, Andrew Sussman (EVP & Pres, CVS MinuteClinic) sold 2,844 shares at 105.00 per share price.
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.